216 related articles for article (PubMed ID: 19215023)
61. Behavior of mesenchymal stem cells stained with 4', 6-diamidino-2-phenylindole dihydrochloride (DAPI) in osteogenic and non osteogenic cultures.
Ocarino NM; Bozzi A; Pereira RD; Breyner NM; Silva VL; Castanheira P; Goes AM; Serakides R
Biocell; 2008 Aug; 32(2):175-83. PubMed ID: 18825911
[TBL] [Abstract][Full Text] [Related]
62. In vivo osteogenic capability of human mesenchymal cells cultured on hydroxyapatite and on beta-tricalcium phosphate.
Matsushima A; Kotobuki N; Tadokoro M; Kawate K; Yajima H; Takakura Y; Ohgushi H
Artif Organs; 2009 Jun; 33(6):474-81. PubMed ID: 19473144
[TBL] [Abstract][Full Text] [Related]
63. Circulating plastic adherent mesenchymal stem cells in aged hip fracture patients.
Alm JJ; Koivu HM; Heino TJ; Hentunen TA; Laitinen S; Aro HT
J Orthop Res; 2010 Dec; 28(12):1634-42. PubMed ID: 20540091
[TBL] [Abstract][Full Text] [Related]
64. Internalization of mesoporous silica nanoparticles induces transient but not sufficient osteogenic signals in human mesenchymal stem cells.
Huang DM; Chung TH; Hung Y; Lu F; Wu SH; Mou CY; Yao M; Chen YC
Toxicol Appl Pharmacol; 2008 Sep; 231(2):208-15. PubMed ID: 18519141
[TBL] [Abstract][Full Text] [Related]
65. Vitreous cryopreservation of tissue engineered bone composed of bone marrow mesenchymal stem cells and partially demineralized bone matrix.
Yin H; Cui L; Liu G; Cen L; Cao Y
Cryobiology; 2009 Oct; 59(2):180-7. PubMed ID: 19576196
[TBL] [Abstract][Full Text] [Related]
66. Effects of imatinib mesylate in osteoblastogenesis.
Tibullo D; Giallongo C; La Cava P; Berretta S; Stagno F; Chiarenza A; Conticello C; Palumbo GA; Di Raimondo F
Exp Hematol; 2009 Apr; 37(4):461-8. PubMed ID: 19302920
[TBL] [Abstract][Full Text] [Related]
67. Difference in subchondral cancellous bone between postmenopausal women with hip osteoarthritis and osteoporotic fracture: implication for fatigue microdamage, bone microarchitecture, and biomechanical properties.
Li ZC; Dai LY; Jiang LS; Qiu S
Arthritis Rheum; 2012 Dec; 64(12):3955-62. PubMed ID: 23124609
[TBL] [Abstract][Full Text] [Related]
68. Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis.
Lumachi F; Ermani M; Camozzi V; Tombolan V; Luisetto G
Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E60-3. PubMed ID: 19751416
[TBL] [Abstract][Full Text] [Related]
69. In vitro proliferation and osteoblastic phenotype expression of cells derived from human vertebral lamina and iliac crest.
Defino HL; da Silva Herrero CF; Crippa GE; Bellesini LS; Beloti MM; Rosa AL
Spine (Phila Pa 1976); 2009 Jul; 34(15):1549-53. PubMed ID: 19564764
[TBL] [Abstract][Full Text] [Related]
70. Osteogenic potential of cryopreserved human bone marrow-derived mesenchymal stem cells cultured with autologous serum.
Matsuo A; Yamazaki Y; Takase C; Aoyagi K; Uchinuma E
J Craniofac Surg; 2008 May; 19(3):693-700. PubMed ID: 18520385
[TBL] [Abstract][Full Text] [Related]
71. The N- and C-terminal domains of parathyroid hormone-related protein affect differently the osteogenic and adipogenic potential of human mesenchymal stem cells.
Casado-Diaz A; Santiago-Mora R; Quesada JM
Exp Mol Med; 2010 Feb; 42(2):87-98. PubMed ID: 19946180
[TBL] [Abstract][Full Text] [Related]
72. Growth factors reduce the suppression of proliferation and osteogenic differentiation by titanium particles on MSCs.
Jeong WK; Park SW; Im GI
J Biomed Mater Res A; 2008 Sep; 86(4):1137-44. PubMed ID: 18442110
[TBL] [Abstract][Full Text] [Related]
73. Altered Expression of Wnt Signaling Pathway Components in Osteogenesis of Mesenchymal Stem Cells in Osteoarthritis Patients.
Tornero-Esteban P; Peralta-Sastre A; Herranz E; Rodríguez-Rodríguez L; Mucientes A; Abásolo L; Marco F; Fernández-Gutiérrez B; Lamas JR
PLoS One; 2015; 10(9):e0137170. PubMed ID: 26352263
[TBL] [Abstract][Full Text] [Related]
74. Locally applied osteogenic predifferentiated progenitor cells are more effective than undifferentiated mesenchymal stem cells in the treatment of delayed bone healing.
Peters A; Toben D; Lienau J; Schell H; Bail HJ; Matziolis G; Duda GN; Kaspar K
Tissue Eng Part A; 2009 Oct; 15(10):2947-54. PubMed ID: 19302033
[TBL] [Abstract][Full Text] [Related]
75. A case of chondromatosis indicates a synovial stem cell aetiology.
Crawford A; Frazer A; Lippitt JM; Buttle DJ; Smith T
Rheumatology (Oxford); 2006 Dec; 45(12):1529-33. PubMed ID: 16670157
[TBL] [Abstract][Full Text] [Related]
76. Mevinolin enhances osteogenic genes (ALP, type I collagen and osteocalcin), CD44, CD47 and CD51 expression during osteogenic differentiation.
Kim HK; Cho SG; Kim JH; Doan TK; Hu QS; Ulhaq R; Song EK; Yoon TR
Life Sci; 2009 Feb; 84(9-10):290-5. PubMed ID: 19162043
[TBL] [Abstract][Full Text] [Related]
77. Distribution and differentiation of mesenchymal stem cells in tumor tissue.
Zhao HF; Chen J; Xu ZS; Zhang KQ
Chin Med J (Engl); 2009 Mar; 122(6):712-5. PubMed ID: 19323940
[TBL] [Abstract][Full Text] [Related]
78. The effect of autologous serum obtained after fracture on the proliferation and osteogenic differentiation of mesenchymal stem cells.
Pountos I; Georgouli T; Giannoudis PV
Cell Mol Biol (Noisy-le-grand); 2008 Oct; 54(1):33-9. PubMed ID: 18954549
[TBL] [Abstract][Full Text] [Related]
79. Vertebral Bone Marrow-Derived Mesenchymal Stromal Cells from Osteoporotic and Healthy Patients Possess Similar Differentiation Properties In Vitro.
Haddouti EM; Randau TM; Hilgers C; Masson W; Pflugmacher R; Burger C; Gravius S; Schildberg FA
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167522
[TBL] [Abstract][Full Text] [Related]
80. MicroRNA-200a-3p accelerates the progression of osteoporosis by targeting glutaminase to inhibit osteogenic differentiation of bone marrow mesenchymal stem cells.
Lv R; Pan X; Song L; Sun Q; Guo C; Zou S; Zhou Q
Biomed Pharmacother; 2019 Aug; 116():108960. PubMed ID: 31112871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
